ERBB2 and breast carcinoma: The Anthracyclines in Early Breast Cancer (ABC) trial was one among many trials designed to compare AC-T to TC (taxane-cyclophosphamide) chemotherapy in the adjuvant setting in patients with early-stage HER2 negative breast cancer.